{
  "format": "listen-step-protocol@1",
  "kind": "module",
  "name": "Optimized DOPE/CHEMS pH-sensitive liposomes",
  "tags": [
    "Liposome",
    "Literature recipe"
  ],
  "steps": [],
  "labItems": [
    {
      "id": "component-dope-chems-ph-sensitive-liposomes",
      "kind": "recipe",
      "afterStep": 0,
      "snapshot": {
        "id": "literature-dope-chems-ph-sensitive-liposomes",
        "kind": "recipe",
        "name": "Optimized DOPE/CHEMS pH-sensitive liposomes",
        "category": "Liposome",
        "tags": [
          "Liposome",
          "Literature recipe"
        ],
        "steps": [],
        "materials": [
          {
            "name": "DOPE",
            "detail": "DOPE:CHEMS 2.2:1 molar ratio"
          },
          {
            "name": "CHEMS",
            "detail": "Cholesteryl hemisuccinate; stabilizes DOPE lamellar form at neutral/alkaline pH"
          },
          {
            "name": "DSPE-PEG2000",
            "detail": "0.5 mol%"
          },
          {
            "name": "Docetaxel",
            "detail": "DTX:total lipid 1:30 mol:mol"
          },
          {
            "name": "Chloroform",
            "detail": "2 mL for lipid-film preparation"
          },
          {
            "name": "PBS pH 7.4",
            "detail": "5 mL for lipid-film hydration"
          }
        ],
        "tables": [
          {
            "id": "optimized-composition",
            "name": "Optimal-D composition",
            "header": [
              "Component",
              "Ratio / concentration",
              "Role"
            ],
            "rows": [
              [
                "DOPE:CHEMS",
                "2.2:1 mol:mol",
                "pH-sensitive membrane"
              ],
              [
                "DSPE-PEG2000",
                "0.5 mol%",
                "Fixed PEGylated component"
              ],
              [
                "Docetaxel:total lipid",
                "1:30 mol:mol",
                "Payload-to-lipid ratio"
              ],
              [
                "Chloroform",
                "2 mL",
                "Lipid-film solvent"
              ],
              [
                "PBS pH 7.4",
                "5 mL",
                "Lipid-film hydration"
              ]
            ]
          },
          {
            "id": "optimized-process-result",
            "name": "Optimized condition and reported result",
            "header": [
              "Parameter",
              "Value",
              "Context"
            ],
            "rows": [
              [
                "Sonication",
                "2.5 min at 40% amplitude; 5/2 on/off cycles",
                "Optimal-D preparation"
              ],
              [
                "Encapsulation efficiency",
                "88.65%",
                "Experimental result"
              ],
              [
                "Diameter",
                "107.17 nm",
                "Experimental result"
              ],
              [
                "PDI",
                "0.213",
                "Experimental result"
              ]
            ]
          }
        ],
        "tableChoices": {},
        "author": "Listen Step",
        "origin": {
          "type": "curated-literature",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10052572/",
          "reviewedAt": "2026-11-09"
        },
        "source": {
          "citation": "Moreira TDS et al. DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics 15, 915 (2023).",
          "doi": "10.3390/pharmaceutics15030915",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10052572/",
          "locator": "Section 2.1, Preparation of pH-Sensitive Liposomes; Section 3, Optimal-D formulation"
        },
        "review": {
          "status": "source-values-checked",
          "reviewedAt": "2026-11-09",
          "scope": "Base optimized research formulation only; cetuximab functionalization is not included. Not a clinical manufacturing or treatment protocol."
        },
        "createdAt": 1794182400000,
        "updatedAt": 1794182400000
      }
    }
  ],
  "materials": [
    {
      "name": "DOPE",
      "detail": "DOPE:CHEMS 2.2:1 molar ratio"
    },
    {
      "name": "CHEMS",
      "detail": "Cholesteryl hemisuccinate; stabilizes DOPE lamellar form at neutral/alkaline pH"
    },
    {
      "name": "DSPE-PEG2000",
      "detail": "0.5 mol%"
    },
    {
      "name": "Docetaxel",
      "detail": "DTX:total lipid 1:30 mol:mol"
    },
    {
      "name": "Chloroform",
      "detail": "2 mL for lipid-film preparation"
    },
    {
      "name": "PBS pH 7.4",
      "detail": "5 mL for lipid-film hydration"
    }
  ],
  "source": {
    "citation": "Moreira TDS et al. DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics 15, 915 (2023).",
    "doi": "10.3390/pharmaceutics15030915",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10052572/",
    "locator": "Section 2.1, Preparation of pH-Sensitive Liposomes; Section 3, Optimal-D formulation"
  },
  "review": {
    "status": "source-values-checked",
    "reviewedAt": "2026-11-09"
  }
}
